Published 18:41 IST, July 24th 2024
Lenacapavir: Landmark Study Finds 100 pc Efficacy In Anti-HIV Drug
Lenacapavir, injectable twice a year, is developed by the US-based biopharmaceutical company Gilead Sciences,
Drugs shows 100 percent efficacy | Image:
Freepik
Advertisement
18:41 IST, July 24th 2024